Enoxaparin Sodium - NDC Database (Page 3)
11797-757 Apr 01, 2021
Enoxaparin Sodium 30 mg/.3ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
Enoxaparin Sodium 30 mg/.3ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
11797-758 Apr 01, 2021
Enoxaparin Sodium 40 mg/.4ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
Enoxaparin Sodium 40 mg/.4ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
11797-759 Apr 01, 2021
Enoxaparin Sodium 60 mg/.6ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
Enoxaparin Sodium 60 mg/.6ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
11797-760 Apr 01, 2021
Enoxaparin Sodium 80 mg/.8ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
Enoxaparin Sodium 80 mg/.8ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
11797-761 Apr 01, 2021
Enoxaparin Sodium 100 mg/ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
Enoxaparin Sodium 100 mg/ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
11797-762 Apr 01, 2021
Enoxaparin Sodium 120 mg/.8ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
Enoxaparin Sodium 120 mg/.8ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
11797-763 Apr 01, 2021
Enoxaparin Sodium 150 mg/ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
Enoxaparin Sodium 150 mg/ml Intravenous; Subcutaneous Injection, Solution by Italfarmaco Spa
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.